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Laurent Parry1,2, Céline Jousse1,2, Alain Bruhat1,2, Anne-Catherine Maurin1,2,  
Philippe Pierre3,4,5,6, Christopher G. Proud7,8 & Pierre Fafournoux1,2
It is well known that the GCN2 and mTORC1 signaling pathways are regulated by amino acids and 
share common functions, in particular the control of translation. The regulation of GCN2 activity by 
amino acid availability relies on the capacity of GCN2 to sense the increased levels of uncharged tRNAs 
upon amino acid scarcity. In contrast, despite recent progress in the understanding of the regulation of 
mTORC1 by amino acids, key aspects of this process remain unsolved. In particular, while leucine is well 
known to be a potent regulator of mTORC1, the mechanisms by which this amino acid is sensed and 
control mTORC1 activity are not well defined. Our data establish that GCN2 is involved in the inhibition 
of mTORC1 upon leucine or arginine deprivation. However, the activation of GCN2 alone is not 
sufficient to inhibit mTORC1 activity, indicating that leucine and arginine exert regulation via additional 
mechanisms. While the mechanism by which GCN2 contributes to the initial step of mTORC1 inhibition 
involves the phosphorylation of eIF2α, we show that it is independent of the downstream transcription 
factor ATF4. These data point to a novel role for GCN2 and phosphorylation of eIF2α in the control of 
mTORC1 by certain amino acids.
The control of cell growth is tightly coupled to the level of protein synthesis, which in turn is controlled by nutri-
ent availability. Among nutrients, amino acids exert a major role on protein synthesis regulation through the 
control of the kinases mTOR (mammalian [or mechanistic] Target Of Rapamycin) and GCN2 (General Control 
Non-derepressible 2) which have opposing effects on protein synthesis. In mammals, the potential regulatory 
interactions between these two pathways are still poorly understood. mTOR, as part of the complex mTORC1, 
is activated by the presence of amino acids1 and phosphorylates the eIF4E-binding proteins, the S6 kinases and 
eukaryotic elongation factor 2 kinase, all of which events favor protein synthesis2,3. GCN2 is activated during 
scarcity of an essential amino acid and phosphorylates the α -subunit of eukaryotic initiation factor 2 alpha 
(eIF2α )4. This leads to the general inhibition of protein synthesis. However, the phosphorylation of eIF2α actu-
ally promotes the translation of certain mRNAs that possess uORFs (upstream Open Reading Frames) in their 
5′ -UTRs, an example of such an mRNA being that encoding the transcription factor activating transcription 
factor 4 (ATF4)5. ATF4 plays a key role in the adaptation of the cell to the lack of amino acids by regulating the 
expression, of amino acid transporters6, enzymes involved in amino acid metabolism7 or factors involved in 
autophagy8.
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Recent years have seen important advances in the understanding of the regulation of mTORC1 by amino 
acids9. The current model involves the control of mTOR localization at the level of the lysosomal membrane by 
the Rags, a family of small GTPases10,11. However, the lysosome is not the only location where mTORC1 can be 
activated12,13. This illustrates that our understanding of the mechanisms involved in the sensing of amino acids 
remains incomplete. There is another level of complexity in the regulation of mTORC1 by amino acids regarding 
the effects of a starvation/stimulation of all amino acids or for a single amino acid. In particular, leucine has been 
the focus of many studies, as it is one of the most potent regulators of mTORC1 signaling14. The mechanisms 
involved in the regulation of mTORC1 by leucine or by other amino acids seem to be distinct; in particular, 
leucine can control mTORC1 activity without modifying the lysosomal localization of mTOR12. In addition, it is 
evident that the mechanisms involved in the sensing of all the amino acids or leucine alone are, at least in part, 
distinct.
Beside its action on mTORC1 signaling, it is well established that leucine is a potent regulator of the kinase 
GCN2. The activation of GCN2 by amino acid starvation is mediated by the levels of uncharged tRNA; such 
tRNAs bind to and activate GCN215. Previous work has established that GCN2 participates in the regulation 
of mTORC1 activity by leucine16,17. These two studies observed that a diet devoid of leucine failed to inhibit 
mTORC1 activity in the liver of GCN2−/− mice, whereas it did impair mTORC1 signaling in wild-type mice. 
This suggests that GCN2 acts upstream of mTORC1. In agreement with this hypothesis, an analogous result was 
observed in HepG2 cells knocked-down for GCN2 and starved for leucine for 24 hours16. It is conceivable that a 
transcriptional target of ATF4 mediates the inhibitory effect of GCN2 activation on mTORC1. Indeed, in contexts 
other than amino acid deprivation, such as endoplasmic reticulum stress or virus infection, two targets of ATF4, 
REDD1 and GADD34, are known to inhibit mTORC1 activity18,19. However, since the inhibition of mTORC1 
signaling by leucine deprivation is rapid12, the contribution of such transcriptional mechanisms is questionable 
given the inherent delay between increased translation of ATF4, the rise in ATF4 protein levels and subsequent 
downstream transcription-dependent events.
This study aimed at investigating more deeply the contribution of GCN2 to the regulation of mTORC1 by 
leucine deprivation. Our data demonstrate that GCN2 is necessary for the early effect of leucine deprivation on 
mTORC1 signaling and that this operates independently of ongoing transcription. Furthermore, our data estab-
lish that the phosphorylation of eIF2α is necessary but not sufficient for the inhibition of mTORC1 during leucine 
deprivation. Importantly, we show that the role of GCN2 in the inhibition of mTORC1 is not restricted to leucine 
deprivation, since the ability of arginine deprivation to inhibit mTORC1 also depends on GCN2.
Results
GCN2 is necessary for mTORC1 inhibition by leucine deprivation. To examine the role of GCN2 
in the inhibition of mTORC1 activity we first performed a time-course of leucine deprivation in mouse embry-
onic fibroblasts (MEFs). By 30 min, leucine starvation increased the phosphorylation of eIF2α (Fig. 1A) and 
also inhibited mTORC1 activity as shown by the decrease in the level of phosphorylation of its direct substrate 
S6 kinase 1 (S6K1). The effect of leucine deprivation on S6K1 phosphorylation was transient, a recovery of the 
phosphorylation being observed between 2 and 4 h of starvation. This phenomenon may reflect the fact that the 
induction of proteolysis, and notably autophagy, upon leucine deprivation may enhance the intracellular levels of 
the missing amino acid8,20.
We then focused on the shorter times of starvation and explored the effect of the absence of the eIF2α kinase 
GCN2 on the regulation of S6K1 phosphorylation. As expected, leucine deprivation failed to induce eIF2α 
phosphorylation in GCN2−/− MEFs (Fig. 1B). In contrast to the situation for the wild-type (WT) MEFs, we 
did not observe a consistent or significant decrease in S6K1 phosphorylation during leucine deprivation, at any 
time-point tested. This observation was confirmed by the study of the phosphorylation of 4E-BP1, the second 
well-known target of mTORC1 (Fig. S1). In the WT MEFs a decrease of the phosphorylation was observed after 
30 and 60 minutes of leucine deprivation whereas no effect was observed in the GCN2−/− MEFs. The level of 
mTOR phosphorylation at serine 2448 was also assessed. A moderate but significant decrease of the phospho-
rylation of this site was measured in the WT MEFs after 30 minutes of leucine deprivation. Consistently with 
the level of phosphorylation of S6K1 and 4E-BP1, no decrease of mTOR phosphorylation was observed in the 
GCN2−/− MEFs following leucine deprivation. This result implies that GCN2 is necessary for the rapid inhibition 
of mTORC1 activity by leucine deprivation.
Since the mechanisms involved in the regulation of mTORC1 by leucine or by all amino acid appear to differ, 
we wanted to evaluate the role of GCN2 in the inhibition of mTORC1 during starvation of cells for all amino 
acids. The data in Fig. 1C show that this manipulation was still able to strongly decrease S6K1 phosphorylation 
in GCN2−/− MEFs. This demonstrates that GCN2 is not required for the inhibitory effect of general amino acid 
starvation on mTORC1 signaling, in contrast to the situation of starvation for leucine alone. In order to assess 
the idea that GCN2 contributes to the rapid modulation of mTORC1 activity specifically by leucine, we took 
advantage of the ability of total amino acid deprivation to inhibit S6K1 phosphorylation in GCN2−/− MEFs and 
tested the role of GCN2 in the re-activation of mTORC1 when amino acids are resupplied. Following a one-hour 
AA starvation (− AA), cells were resupplied for 15 min with all amino acids (+ AA) or all amino acids without 
leucine (-Leu). In WT MEFs, medium lacking leucine was unable to stimulate mTORC1 activity, whereas in 
GCN2−/− cells this medium did induce S6K1 phosphorylation indicating activation of mTORC1 (Fig. 1D). This 
result demonstrates that, in the absence of GCN2, leucine is dispensable for the activation of mTORC1 by the 
other amino acids. Taken together, these experiments demonstrate that GCN2 plays a central role in the regu-
lation of mTORC1 activity by leucine and that this is distinct from the control of mTORC1 signaling by amino 
acids in general.
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ATF4 is not required for the short-term effect of leucine deprivation on mTORC1 signaling. 
The fact that GCN2 acts in the early events of the regulation of mTORC1 led us to assess the role of ATF4, a tran-
scription factor whose expression is controlled by GCN221, in this process. We investigated the effect of leucine 
starvation on mTORC1 activity in ATF4−/− MEFs. As in the wild-type cells, inhibition of S6K1 phosphorylation 
was still seen at the earliest time of leucine starvation (Fig. 2A). The same observation was made for the level 
of phosphorylation of 4E-BP1 and mTOR (Fig. S1). It can be concluded that ATF4 is not involved in mTORC1 
inhibition at early times of leucine starvation. We then performed the same type of experiment of starvation/
stimulation as in Fig. 1D. No significant difference was observed between the WT and ATF4−/− cells suggesting 
that ATF4 is not involved in maintaining mTORC1 inhibition at least in the context of short-term amino acid 
deprivation (Fig. 2B). Because ATF4 is not the only transcription factor, or protein, that is induced at the trans-
lational level by phosphorylation of eIF2α , we also tested the effect of actinomycin D, a transcription inhibitor. 
This experiment demonstrated that ongoing transcriptional activity is not required for the inhibition of mTORC1 
activity by leucine starvation (Fig. S2). These findings emphasize that GCN2 acts independently of ATF4 or any 
other transcriptional event to regulate mTORC1 signaling.
Figure 1. GCN2 is necessary for mTORC1 regulation by leucine. (A) Wild-Type (WT) MEFs were 
transferred to fresh medium containing dialysed serum and all amino acids except leucine, and then maintained 
in the presence or in absence of leucine (Leu) for the times indicated (minutes). Immunoblot analyses were 
performed on the resulting cell lysates using the indicated antibodies. The ratio of phosphorylated S6K1 
(Thr389) to total S6K1 was determined by densitometry analysis, differences between control cells (dark bars)
and leucine starved cells (light bars) at each time point were assessed by 1-way ANOVA. Bars with (*) are 
significantly different from each other (P < 0.05). (B) WT or GCN2-KO (− /− ) MEFs were maintained in all 
amino acids including or excluding leucine (Leu) for the times indicated. The ratio of phosphorylated S6K1 
(Thr389) to total S6K1 was determined by densitometry analysis, differences between control cells and leucine 
starved cells at each time point were assessed by 1-way ANOVA. Bars with (*) are significantly different from 
each other (P < 0.05). (C) WT or GCN2−/− MEFs were cultured in presence or in absence of all amino acids 
(AA) for the times shown. (D) WT and GCN2−/− MEFs were kept in the presence (+ AA) or absence (− AA) 
of AA for 75 min; or in the absence of AA for 60 min prior to addition for 15 min of a medium containing all 
AA (− AA → + AA) or a medium containing all AA except leucine (− AA → -Leu). In all panels, immunoblot 
analyses were performed on the resulting cell lysates using the indicated antibodies.
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The phosphorylation of eIF2α is necessary but not sufficient to inhibit mTORC1 activity upon 
leucine deprivation. We then examined the role of eIF2α phosphorylation in the regulation of mTORC1 
signaling by leucine. For this purpose, we used eIF2α S51A/S51A MEFs in which eIF2α has been mutated at Ser51 and 
so cannot be phosphorylated. In this cell line, leucine starvation was unable to inhibit S6K1, 4E-BP1 and mTOR 
phosphorylation (Figs 3A and S1) whereas deprivation of all amino acids did still inhibit S6K1 phosphorylation 
(Fig. 3B). Furthermore, following the inhibition of mTORC1 activity by the withdrawal of amino acids, addition 
of medium lacking leucine was still able to induce the phosphorylation of S6K1 (Fig. 3B) in eIF2α S51A/S51A MEFs, 
Figure 2. ATF4 is not involved at early times of mTORC1 regulation by leucine. (A) WT or GCN2−/− MEFs 
were cultured in presence or in absence of leucine (Leu) with all the other AAs for 30 min, 60 min or 120 min. 
The ratio of phosphorylated S6K1 (Thr389) to total S6K1 was determined by densitometry analysis, differences 
between control cells (dark bars) and leucine starved cells (light bars) at each time point were assessed by 1-way 
ANOVA. Bars with (*) are significantly different from each other (P < 0.05). (B) WT MEFs and ATF4−/− MEFs 
were cultured in the presence or absence of AA for 75 min; or in absence of AA for 60 min prior to addition for 
15 min of a medium containing all AA (− AA → + AA) or a medium containing all AA except leucine (− AA 
→ -Leu). In all panels, immunoblot analyses were performed on the resulting cell lysates using the indicated 
antibodies.
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whereas this medium was unable to induce S6K1 phosphorylation in WT MEFs. We studied whether leucine 
deprivation induced activation of GCN2 in eIF2α S51A/S51A MEFs; a significant increase in the phosphorylation of 
GCN2 at threonine 898 was observed in this cell line (Fig. S3). These results demonstrate that the phosphoryla-
tion of eIF2α is a necessary event in the inhibition of mTORC1 by GCN2 activation upon starvation for leucine.
We subsequently investigated whether inducing the phosphorylation of eIF2α was sufficient to inhibit 
mTORC1. We used tunicamycin to increase eIF2α phosphorylation; this drug induces endoplasmic reticulum 
stress and the activation of a different eIF2α kinase, PERK. As expected, this treatment increased the phosphoryl-
ation of eIF2α , but also the phosphorylation of S6K1 (Fig. 4A). This could perhaps be explained by the fact that 
Figure 3. The phosphorylation of eIF2α is necessary for the regulation of mTORC1 by leucine. (A) WT or 
eIF2α [Ser51Ala] MEFs were maintained in presence or in absence of leucine (Leu) with all the other AAs for 
the times shown. A positive control has been included in the immunoblot analysis for the phosphorylated eIF2α 
in the eIF2α [Ser51Ala] MEFs. The ratio of phosphorylated S6K1 (Thr389) to total S6K1 was determined by 
densitometry analysis, differences between control cells (dark bars) and leucine starved cells (light bars) at each 
time point were assessed by 1-way ANOVA. Bars with (*) are significantly different from each other (P < 0.05). 
(B) WT or eIF2α [Ser51Ala] MEFs were kept in the presence or absence of AA for 75 min + AA); or in the 
absence of AA (− AA) for 60 min prior to addition for 15 min of a medium containing all AA (− AA → + AA) 
or a medium containing all AA except leucine (− AA → -Leu). A positive control has been included in the 
immunoblot analysis for the phosphorylated eIF2α in the eIF2α [Ser51Ala] MEFs. Immunoblot analyses were 
performed to measure the amounts of the indicated proteins and their levels of phosphorylation.
www.nature.com/scientificreports/
6Scientific RepoRts | 6:27698 | DOI: 10.1038/srep27698
eIF2α phosphorylation inhibits translation and so can evoke a transient rise in the intracellular levels of amino 
acids that in turn induces the activation of mTORC1. This phenomenon has been already observed with another 
protein synthesis inhibitor, cycloheximide22. These results demonstrate that the induction of eIF2α phosphoryla-
tion by itself is not sufficient to inhibit mTORC1 activity.
The finding that the phosphorylation of eIF2α is necessary but not sufficient to inhibit mTORC1 led us to 
postulate that the activation of GCN2 alone might be not sufficient. To test this hypothesis, cells were treated with 
histidinol, a structural analogue of histidine that inhibits the charging of the histidyl-tRNA23 and in consequence 
activates GCN2. A induction of eIF2α phosphorylation was observed in cells treated with histidinol (Fig. 4B). 
This was accompanied by an induction of the phosphorylation of S6K1, which might again be explained by a tran-
sient rise in the intracellular level of amino acids due to inhibition of protein synthesis (and thus of amino acid 
utilization)22. As hypothesized, activation of GCN2 by itself does not seem sufficient to inhibit mTORC1 activity. 
In order to confirm this, cells were starved for lysine, since lysine deprivation efficiently induces the GCN2/ATF4 
pathway in MEFs24 although there were no clear data concerning the effect of this condition on mTORC1 sign-
aling. Indeed, despite the increase in eIF2α phosphorylation induced by lysine deprivation, we did not observe 
any change in S6K1 phosphorylation (Fig. 4C). Moreover, following the inhibition of S6K1 phosphorylation by 
amino acid deprivation, medium lacking lysine induced S6K1 phosphorylation to the same extent as the complete 
medium (Fig. 4D). These results confirm that the activation of GCN2 does not necessarily result in mTORC1 
inhibition, even though both GCN2 and phosphorylation of eIF2α are required for inhibition of mTORC1. The 
corollary of this observation is that additional events controlled by leucine deprivation are required to inhibit 
mTORC1 activity.
GCN2 is also necessary for the inhibition of mTORC1 activity during arginine deprivation. We 
wondered whether the role of GCN2 was restricted only to leucine deprivation. Among amino acids, it is well 
known that arginine is also potent regulator of mTORC1 activity. Moreover, previous studies have demon-
strated that arginine can control eIF2α phosphorylation25. We therefore tested the contribution of GCN2 to the 
Figure 4. The phosphorylation of eIF2α is not sufficient to inhibit mTORC1. (A) WT MEFs were treated 
without (Ctl) or with tunicamycin (Tun) for the times shown. (B) WT MEFs were treated without (Ctl) or 
with histidinol (Hol) for the times shown. (C) WT MEFs were cultured in the presence or in absence of lysine 
(Lys) with all the other AAs for the indicated times. (D) WT MEFs were cultured in the presence or absence 
of AA for 75 min (+ AA); or in absence of AA for 60 min prior to addition for 15 min of a medium containing 
all AA (− AA → + AA) or a medium containing all AA except leucine (− AA → -Leu) or lysine (− AA → -Lys). 
Immunoblot analyses were performed to measure the amounts of the indicated proteins and their levels of 
phosphorylation.
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regulation of mTORC1 by arginine. The data in Fig. 5A illustrate that, in WT MEFs, arginine deprivation induces 
eIF2α phosphorylation and decreases S6K1 phosphorylation. In contrast, in GCN2−/− cells, the regulation of 
S6K1 phosphorylation by arginine was abolished. The same observation was made for 4E-BP1 and mTOR phos-
phorylation (Fig. S4). Then, the experimental model of starvation/stimulation was used. Following amino acid 
deprivation, the addition of a medium containing all amino acids except arginine was unable to induce S6K1 
phosphorylation in WT MEFs, whereas this same medium efficiently induced the phosphorylation of S6K1 in 
GCN2−/− MEFs (Fig. 5B). All these data demonstrate that GCN2 is also necessary for the regulation of mTORC1 
by arginine and thus that the role of GCN2 in the control of mTORC1 is not restricted to leucine deprivation.
Figure 5. GCN2 is necessary for the regulation of mTORC1 by arginine. (A) WT or GCN2−/− MEFs were 
cultured in presence or in absence of arginine (Arg) with all the other AAs for 30, 60 or 120 min. The ratio of 
phosphorylated S6K1 (Thr389) to total S6K1 was determined by densitometry analysis, differences between 
control cells (dark bars) and arginine starved cells (light bars) at each time point were assessed by 1-way 
ANOVA. Bars with (*) are significantly different from each other (P < 0.05). (B) WT MEFs and GCN2−/− MEFs 
were cultured in the presence or absence of AA for 75 min; or in absence of AA for 60 min prior to addition 
for 15 min of a medium containing all AA (− AA → + AA) or a medium containing all AA except arginine 
(− AA → -Arg). Immunoblot analyses were performed to assess the amounts of the indicated proteins and their 
levels of phosphorylation.
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8Scientific RepoRts | 6:27698 | DOI: 10.1038/srep27698
Discussion
Our study reinforces the conclusion that regulation of mTORC1 by amino acids is complicated and is not limited 
to a single mechanism26. This is underscored by the fact that the regulation of mTORC1 by all amino acids differs 
from its control by individual amino acids such as leucine. The present study demonstrates that GCN2 plays an 
indispensable role in the inhibition of mTORC1 activity in response to leucine or arginine deprivation in mouse 
embryonic fibroblasts. However, our study also shows that activation of GCN2 is not itself sufficient to inhibit 
mTORC1. The observation that lysine deprivation over a short time period did not inhibit mTORC1 whereas 
it did induce GCN2 activation clearly illustrates this. It remains puzzling, in terms of biological significance, 
that deprivation for some amino acids induces GCN2 activation and inhibits mTORC1 whereas starvation for 
others only activates GCN2. It is very important to bear in mind that the ability of a given amino acid to control 
mTORC1 may differ according to the cell type. This illustrates the challenges of understanding the regulation of 
mTORC1 by single amino acids. Understanding this evident complexity is made harder by the fact that various 
different protocols have been used to study this regulation, e.g., cells maintained in the presence or absence of 
serum, or studying the effect of an amino acid in the presence or in the absence of other amino acids. These 
aspects might well be confounding when the results of different studies are evaluated.
One major finding of our study is that GCN2 acts in the early stages of mTORC1 inhibition independently 
of ATF4 or ongoing transcription. Thus, while one might speculate that transcriptional targets of ATF4 such 
REDD118 could be involved in the inhibition of mTORC1 under such conditions, our results clearly demonstrate 
that GCN2 contributes to the early stages of mTORC1 inhibition in the absence of ATF4 and even of ongoing 
transcriptional activity. Importantly, our data do not contradict the possibility that the ATF4 target genes may 
contribute to maintaining mTORC1 inhibition upon prolonged leucine deprivation. Indeed, a faster recovery of 
S6K1 phosphorylation seems to occur in ATF4−/− MEFs after 2 h of leucine deprivation (Fig. 2A). In the con-
text of serum deprivation, it has been demonstrated that REDD1 sustains the repression of mTORC1 but is not 
responsible for the initial inhibition18.
According to our results obtained with eIF2α S51A/S51A MEFs, the phosphorylation of eIF2α is necessary for 
the inhibition of mTORC1 signaling in amino acid-deprived cells. However, given that lack of need for ATF4, 
which can be translationally upregulated following eIF2α phosphorylation, the mechanism by which phospho-
rylation of eIF2α controls mTORC1 remains to be identified. The phosphorylation of eIF2α inhibits the gua-
nine nucleotide-exchange activity of eIF2B; consequently, eIF2 remains in its inactive GDP-bound form and the 
formation of the 43S ribosomal preinitiation complex is abolished27. Holtz et al.28 have described that mTOR 
interacts with a multisubunit translation factor, eIF3, to regulate the formation of the preinitiation complex. Thus, 
the inhibition of the formation of the 43S preinitiation complex by eIF2α phosphorylation could impact on the 
localization of mTORC1 and thus on its regulation. Interestingly, a study which was published while we were 
finalizing our manuscript29, emphasizes the importance of the translation pre-initiation complex, in particularly 
eIF4A, in the regulation of mTORC1 activity.
The fact that GCN2 activation is necessary but not sufficient to inhibit mTORC1 signaling indicates the exist-
ence of additional mechanisms invoked by leucine or arginine deprivation30,31. Concerning arginine, the recent 
study by Wang et al.30 demonstrated that the amino acid transporter SCL38A9 is responsible for the regulation 
of mTORC1 specifically by arginine. This transporter is located at the lysosomal membrane and interacts with 
the Ragulator complex and the Rag proteins. Several mechanisms have been proposed to explain the regulation 
of mTORC1 by leucine, all of which are thought to rely upon the regulation of the Rag proteins and the locali-
zation of mTORC1 at the lysosome32,33. Finally, while we were finalizing our study, Wolfson et al.34 established 
that Sestrin2 (sesn2), an inhibitor of mTORC1 activity, is a sensor of leucine availability and that its presence is 
necessary for mTORC1 regulation by leucine availability. Even more recently, Ye et al.35 demonstrated that sesn2 
is a target gene of the GCN2/ATF4 pathway and that its transcriptional activation is required to sustain mTORC1 
inhibition upon leucine deprivation. The authors also showed that sesn2 is needed for signaling the inhibition 
of mTORC1 upon long-term deprivation (24 h) of other amino acids such arginine. Given that Wolfson et al.34 
demonstrated that Sestrin2 does not bind arginine, it will be important to determine how the increase of the 
expression of Sestrin2 contributes to the inhibitory effect of 24 h arginine deprivation.
It remains difficult to establish a unifying model that integrates the available data concerning the roles of 
GCN2 and Sestrin2 in the regulation of mTORC1 by individual amino acids. Concerning the setting of leucine 
deprivation, Sestrin2 appears to be a crucial regulator of mTORC1 activity through its ability to bind leucine34. In 
addition, it is clear that GCN2 and ATF4 contribute to the regulation of mTORC1 by Sestrin2 through the induc-
tion of its expression during leucine deprivation35. Nevertheless, as discussed above, GCN2 provides an additional 
input to mTORC1 signaling that does not require ATF4 expression or, therefore, the induction of sesn2. This 
interpretation is reinforced by the fact that GCN2 is also necessary for inhibition of mTORC1 upon short-term 
arginine deprivation whereas Sestrin2 does not appear to be directly involved in sensing arginine or the effects of 
arginine on mTORC1 signaling34.
The present study establishes that, in the context of mTORC1 regulation, GCN2 is a crucial sensor, probably 
of the cytoplasmic levels of leucine and arginine, which, among the amino acids, are the most potent regulators 
of mTORC136. Our results complement the recent advances in the understanding of the mechanisms involved in 
sensing these two amino acids. However, it remains unresolved how GCN2, independently of ATF4, cooperates 
with sensing systems involving Sestrin2 and SLC38A9. It should be borne in mind that the relative contributions 
of these inputs may differ according the cell type and/or the model of amino acid deprivation/stimulation. It will 
be important to determine if the role of GCN2 during leucine or arginine deprivation is related to the control 
of mTORC1 at the level of lysosome, since the ability of mTOR to interact with the lysosome also appears to be 
crucial for mTORC1 inhibition by amino acid starvation12,37. Indeed, we previously observed a strong attenua-
tion of the inhibitory effect of leucine deprivation on mTORC1 signaling in cells knocked down for RagC/D12. 
In addition, Ye et al.35 observed that leucine deprivation was less efficient in decreasing S6K1 phosphorylation 
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in RagA/B-KO cells. A corollary of these experiments is the likely existence of Rag-independent inputs to the 
control of mTORC1. It is conceivable that GCN2 activation contributes to the regulation of mTORC1 in another 
cellular compartment such the Golgi apparatus13.
Our findings add significantly to the body of information on the control of mTORC1 by showing that GCN2 
and the phosphorylation of its substrate eIF2α are important for the control of mTORC1 by leucine, but that this 
can occurs independently of the best-known target of the GCN2/eIF2 pathway, the transcription factor ATF4.
Materials and Methods
Reagents. Antibodies against S6K1 (#9202), S6K phosphorylated at Thr-389 (#9205), eIF2α (#9722) were 
from Cell Signaling Technology, antibody against eIF2α phosphorylated at Ser-51 (ab32157) was from Abcam. 
Dulbecco’s Modified Eagle’s Medium (DMEM) and Dulbecco’s Modified Eagle’s Medium/Nutrient F-12 Ham’s 
DMEM/F12 used for leucine deprived medium were from Sigma. DMEM without amino acids was from 
Genaxxon. DMEM used for arginine deprived medium was from ThermoFisher Scientific. Fetal bovine serum 
(FBS) was from Gibco and had been dialysed (using a membrane with a cut-off of 3500 Da) against phos-
phate-buffered saline (PBS) (pH: 7.4) at 4 °C. MEFs deficient in GCN221 and ATF438 were kindly donated by Prof. 
D. Ron (Institute of Metabolic Science, Cambridge, UK), eIF2α S51A/S51A 39 MEFs were kindly provided by Dr R. J. 
Kaufman (La Jolla, California, University of Michigan, USA). Actinomycin D, tunicamycin and histidinol were 
from Sigma.
Cell culture and treatments. Mouse embryonic fibroblasts (MEFs) were grown in high glucose (4.5 g/liter) 
DMEM with 10% (v/v) FBS, 2 mM L-glutamine, mixture of MEM Non-essential Amino Acids (Invitrogen), 
100 units/ml streptomycin sulfate, and 100 units/ml penicillin G, at 37 °C with 5% (v/v) CO2. For amino acid 
starvation experiments, cells were grown in DMEM containing high glucose and lacking all amino acids in the 
presence or absence of 10% (v/v) dialysed FBS. Cells were washed twice with PBS before starvation. The amino 
acid stimulation was performed by changing the ‘starved’ medium for complete DMEM medium in the presence 
or absence of 10% dialysed FBS. For leucine starvation, cells were grown in DMEM/F12 lacking leucine in the 
presence or absence of 10% dialysed FBS. Cells were rinsed twice with PBS before starvation. Leucine stimulation 
was performed by adding leucine at a final concentration of 450 μ M to the leucine-free medium. All the experi-
ments were repeated at least three times, and those using siRNA were repeated at least five times.
Protein analysis. For protein extraction, lysis was performed with our standard lysis buffer (50 mM Tris, 
25 mM β -glycerophosphate, 50 mM NaCl, 1 mM EDTA, 1 mM EGTA, 0.5% (v/v) Triton X100, 1 mM DTT, 1 mM 
benzamidine, protease and phosphatase inhibitor cocktail (Sigma). SDS-PAGE was performed as previously 
described12. The total protein concentrations were determined using a standard Bradford protein assay. Proteins 
were transferred onto PVDF membrane which was then blocked in Tris-Buffered Saline (TBS) containing 0.1% 
Tween20 and 5% (w/v) non-fat dry milk powder for 1 h at room temperature. The membrane was incubated with 
primary antibody overnight at 4 °C in TBS; 0.1% Tween20, 5% (w/v) non-fat dry milk or 5% (w/v) bovine serum 
albumin (BSA). Antibodies were diluted according to the manufacturer’s instructions. Membranes were washed 
4 times for 5 min in TBS, 0.1% Tween20. Secondary antibodies coupled to HRP, diluted at 1/5000 in TBS, 0.1% 
Tween20, 5% (w/v) non-fat dried milk, was incubated at room temperature for 1 h. Membranes were washed 4 
times for 5 min in TBS, 0.1% Tween20. A final wash of 5 min was performed in TBS. Luminata western HRP sub-
strate (Millipore) and a chemiluminescence imager (G:box, Syngene) were used to detect the signals.
Statistical analyses. All data are expressed as means ± SEM. Differences between sample of a same time 
of treatment and same genotype were assessed by one-way ANOVA (fisher test). Significance was defined at the 
0.05 level.
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